Applications including "Japanese pharmacopoeia"

LT199 - Analysis of voglibose tablets in accordance with the 18th revised Japanese Pharmacopoeia -

LC Technical Note Inertsil NH2
LT195 - Eighteenth revision Japanese Pharmacopoeia analysis of tranexamic acid -2.00 Condition change within the range specified in the general chromatography- -

LC Technical Note InertSustain AQ-C18
GT146 - Japanese Pharmacopoeia, 18th Edition Analysis of Saccharin Sodium Hydrate - 2.00 Change of Conditions Specified within General Theory of Chromatography -

GC Technical Note
GT145 - Japanese Pharmacopoeia, 18th Edition Analysis of Macrogol 400 - 2.00 Change of Conditions Specified within General Theory of Chromatography -

GC Technical Note
LB263 - Analysis of Losartan Potassium and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Losartan Potassium and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB206 - Analysis of Paroxetine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil TMS
LB161 - Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia, Clopidogrel sulfate Tablets) -

LC InertSearch InertSustain C18
LB099 - Analysis of p-Hydroxybenzoic acid n-butyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB094 - Analysis of Pranlukast hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB085 - Analysis of Olmesartan medoxomil (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-2
GA271 - Analysis of Polysorbate80(Under the Condition of Japanese Pharmacopoeia 16) -

GC InertSearch InertCap 5
GA270 - Analysis of Polysorbate80(Under the Condition of Japanese Pharmacopoeia 16) -

GC InertSearch InertCap Pure-WAX
GA113 - Residual solvents in pharmaceuticals -

GC InertSearch InertCap Pure-WAX
GA029 - Organic solvents -

GC InertSearch InertCap WAX
LB849 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -

LC InertSearch Inertsil ODS-4
LB848 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -

LC InertSearch Inertsil ODS-4
LB806 - Analysis of Ampicillin and Sulbactam (Under the Condition of the Japanese Pharmacopoeia 18th , Ampicillin Sodium and Sulbactam Sodium for Injection) -

LC InertSearch Inertsil ODS-HL
LB761 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch Inertsil ODS-4
LB760 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch InertSustain C18
LB759 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch InertSustain AX-C18
LB758 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch InertSustain C18
LB757 - Analysis of Fenofibrate (Under the Condition of the Japanese Pharmacopoeia 18th) -

LC InertSearch Inertsil ODS-4
LB756 - Analysis of Fenofibrate (Under the Condition of the Japanese Pharmacopoeia 18th) -

LC InertSearch Inertsil ODS-4
LB755 - Analysis of Oxaliplatin (Under the Condition of the draft for the Japanese Pharmacopoeia18th supplement II) -

LC InertSearch InertSustainSwift C18
LB754 - Analysis of Saccharin (Under the Condition of the Japanese Pharmacopoeia 18th, Saccharin Sodium Hydrate) -

LC InertSearch Inertsil WP300 C18
GA342 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GC InertSearch InertCap WAX
GA341 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GC InertSearch InertCap WAX
GA340 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GC InertSearch InertCap WAX
GA339 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GC InertSearch InertCap 624MS
GA338 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GC InertSearch InertCap 624MS
GA337 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GC InertSearch InertCap 624MS
LB699 - Analysis of Refined Glucose (Japanese Pharmacopoeia 18th Edition, Glucose, Assay) -

LC InertSearch InertSphere Sugar-2
GA335 - Analysis of Benzyl Alcohol (Under the condition of the Japanese Pharmacopoeia 18) -

GC InertSearch InertCap Pure-WAX
GA333 - Residual solvents in pharmaceuticals (JP 18 Standard stock solution Class 2 C) -

GC InertSearch InertCap WAX
GA332 - Residual solvents in pharmaceuticals (JP 18 Standard stock solution Class 2 C) -

GC InertSearch InertCap 624MS
GA331 - Residual solvents in pharmaceuticals (JP 18 Standard stock solution Class 2 C) -

GC InertSearch InertCap 624MS
GA330 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GC InertSearch InertCap WAX
GA329 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GC InertSearch InertCap 624MS
GA328 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GC InertSearch InertCap 624MS
GA327 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GC InertSearch InertCap WAX
GA326 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GC InertSearch InertCap 624MS
GA325 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GC InertSearch InertCap 624MS
GA324 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GC InertSearch InertCap WAX
GA323 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GC InertSearch InertCap 624MS
GA322 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GC InertSearch InertCap 624MS
LB669 - Analysis of Rosuvastatin calcium (Under the condition of the Japanese Pharmacopoeia (JP) ) -

LC InertSearch InertSustainSwift C18
LB641 - Analysis of Rosuvastatin Calcium (Under the Condition of draft for Japanese Pharmacopoeia, Rosuvastatin Calcium) -

LC InertSearch InertSustain C18
LB640 - Analysis of Rosuvastatin Calcium (Under the Condition of draft for Japanese Pharmacopoeia, Rosuvastatin Calcium) -

LC InertSearch InertSustain C18
LB632 - Analysis of Telmisartan and Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LC InertSearch Inertsil C8-3
LB631 - Analysis of Telmisartan and Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LC InertSearch Inertsil C8-3
LB630 - Analysis of Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LC InertSearch Inertsil C8-3
LB629 - Analysis of Telmisartan (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LC InertSearch Inertsil C8-3
LB628 - Analysis of Copovidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (7) 2-Pyrrolidone) -

LC InertSearch Inertsil ODS-3
LB627 - Analysis of Copovidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (4) 1-Vinyl-2-pyrrolidone and vinyl acetate) -

LC InertSearch Inertsil ODS-4
LT147 - D-Mannitol Analysis Under USP Method -

LC Technical Note InertSphere Sugar-2 HAMILTON HC-75（Ca2+）
LT131 - HPLC Columns Compliant with Pharmacopoeia (USP, EP and JP） -

LC Technical Note
LT092 - Analysis of Tranexamic Acid According to the Japanese Pharmacopoeia -

LC Technical Note InertSustain AQ-C18 Inertsil ODS-4
LT080 - Analysis of Sennosides in Senna in Accordance with the Japanese Pharmacopoeia -

LC Technical Note Inertsil ODS-4
LT052 - Analysis of Geniposide with a Photodiode Array Detection -

LC Technical Note Inertsil ODS-SP
LT044 - Analysis of Bufosteroids in Senso In Accordance with the Japanese Pharmacopoeia -

LC Technical Note Inertsil ODS-P
LT040 - Analysis of peony (Chinese paeoniflorin) in accordance with the 15th edition of the Japanese Pharmacopoeia -

LC Technical Note Inertsil ODS-3 Inertsil ODS-SP
LT039 - Analysis of Glycyrrhizic Acid in Licorice According to the Japanese Pharmacopoeia -

LC Technical Note
LT038 - Analysis of Scopolamine and Hyoscyamine in Scopolia Extract in Accordance with the Japanese Pharmacopoeia -

LC Technical Note Inertsil ODS-SP
LB532 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets B) -

LC InertSearch InertSustain C18
LB531 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets A) -

LC InertSearch InertSustain C18
LB529 - Analysis of Carnosine (Under the Condition of the draft for the Japanese Pharmacopoeia, Poraprezinc Granules) -

LC InertSearch InertSustain C18
LB528 - Analysis of Carnosine (Under the Condition of the draft for the Japanese Pharmacopoeia, Poraprezinc) -

LC InertSearch InertSustain C18
LB527 - Analysis of Dexamathasone Sodium Phosphate (Under the Condition of the draft for the Japanese Pharmacopoeia, Dexamathasone Sodium Phosphate) -

LC InertSearch Inertsil ODS-4
LB526 - Analysis of Dexamathasone Sodium Phosphate (Under the Condition of the draft for the Japanese Pharmacopoeia, Dexamathasone Sodium Phosphate) -

LC InertSearch Inertsil ODS-4
LB525 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of the draft for the Japanese Pharmacopoeia, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB524 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia supplement II, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB523 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of the draft for the Japanese Pharmacopoeia, Telmisartan and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB520 - Analysis of Valsartan and Hydrochlorothiazide(Under the Condition of the draft for the Japanese Pharmacopoeia, Valsartan and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustain C18
LB519 - Analysis of Valsartan and Hydrochlorothiazide(Under the Condition of the draft for the Japanese Pharmacopoeia, Valsartan and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustainSwift C18
LB508 - Analysis of Sitagliptin (Under the Condition of the draft for the Japanese Pharmacopoeia, Sitagliptin Phosphate Hydrate) -

LC InertSearch InertSustain Cyano
LB503 - Analysis of Warfarin Potassium (Under the Condition of the Japanese Pharmacopoeia 17th edition, (3) Related subatances) -

LC InertSearch InertSustain Cyano
LB502 - Analysis of Warfarin Potassium (Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch InertSustain Cyano
LB489 - Analysis of Azosemide (Under the Condition of the draft for the Japanese Pharmacopoeia, Azosemide Tablets) -

LC InertSearch InertSustain C18
LB487 - Analysis of Verapamil Hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Verapamil Hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB486 - Analysis of Clomipramine Hydorochloride (Under the Condition of the Japanese Pharmacopoeia, Clomipramine Hydorochloride Tablets) -

LC InertSearch Inertsil ODS-3
LB485 - Analysis of Pyridoxal Phosphate Hydrate (Under the Condition of the Japanese Pharmacopoeia, (4) Related subatances) -

LC InertSearch InertSustain AQ-C18
LB483 - Analysis of Minocycline Hydrochloride (Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch InertSustainSwift C8
LB482 - Analysis of Glycyrrhiza (Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch Inertsil ODS-4
LB477 - Analysis of Povidone(Under the Condition of the Japanese Pharmacopoeia 17th edition, (7) Formic acid) -

LC InertSearch InertSphere FA-1
LB472 - Analysis of Tramadol Hydrochloride (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C8
LB471 - Analysis of Tramadol Hydrochloride (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB453 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia, Tranexamic acid Capsules) -

LC InertSearch Inertsil ODS-4
LB452 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia, Tranexamic acid Tablets) -

LC InertSearch InertSustain AQ-C18
LB451 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain AQ-C18
LB450 - Analysis of Tranexamic acid(Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain AQ-C18
LB449 - Analysis of Lansoprazole(Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB448 - Analysis of Mesalazine(Under the Condition of the draft for the Japanese Pharmacopoeia, (8) 3-Aminophenol, 3-Aminobenzoic acid, Gentisic acid, Salicylic acid, other related substances and total related substance) -

LC InertSearch InertSustain C8
LB447 - Analysis of Mesalazine(Under the Condition of the draft for the Japanese Pharmacopoeia, (6) 2-Aminophenol and 4-Aminophenol) -

LC InertSearch InertSustainSwift C18 HP
LB446 - Analysis of Hydrocortisone butyrate(Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3 HP
LB445 - Analysis of Pazufloxacin mesilate (Under the Condition of the Japanese Pharmacopoeia 18th edition) -

LC InertSearch Inertsil ODS-3
LB444 - Analysis of Pazufloxacin mesilate(Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-2
LB436 - Analysis of Mesalazine(Under the Condition of the Japanese Pharmacopoeia, (7) Aniline) -

LC InertSearch InertSustain C18
LB435 - Analysis of Povidone(Under the Condition of the Japanese Pharmacopoeia 17th edition, (6) 2-Pyrrolidone) -

LC InertSearch InertSustain AQ-C18
LB433 - Analysis of Povidone(Under the Condition of the Japanese Pharmacopoeia 17th edition, (4) 1-Vinyl-2-pyrrolidone) -

LC InertSearch InertSustain AQ-C18
LB432 - Analysis of Haloperidol(Under the Condition of the Japanese Pharmacopoeia 17th edition, Haloperidol Tablets) -

LC InertSearch Inertsil ODS-4
LB431 - Analysis of Haloperidol(Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch Inertsil ODS-4
LB430 - Analysis of Tulobuterol Hydrochloride(Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch InertSustain C18
LB429 - Analysis of Tulobuterol(Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch InertSustain C18
LB426 - Analysis of Diflorason Diacetate(Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch InertSustain C18
LB425 - Analysis of Diflorason Diacetate(Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LC InertSearch InertSustain C18
LB424 - Analysis of Eplerenone(Under the Condition of the Japanese Pharmacopoeia 17th edition, Eplerenone Tablets) -

LC InertSearch Inertsil ODS-3
LB420 - Analysis of Acetaminophen (Under the Condition of the Japanese Pharmacopoeia) （InertSustainSwift C18） -

LC InertSearch InertSustainSwift C18
LB419 - Analysis of Acetaminophen (Under the Condition of the Japanese Pharmacopoeia) （InertSustain C18） -

LC InertSearch InertSustain C18
LB415 - Analysis of Methotrexate (Under the Condition of the draft for the Japanese Pharmacopoeia, Methotrexate Tablets) -

LC InertSearch Inertsil ODS-4
LB413 - Analysis of Eplerenone (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C18
LB412 - Analysis of Eplerenone (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C18
LB411 - Analysis of Medroxyprogesterone acetate (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB410 - Analysis of Medroxyprogesterone acetate (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB409 - Analysis of Mesalazine (Under the Condition of the draft for the Japanese Pharmacopoeia, Mesalazine Extended-release Tablets) -

LC InertSearch Inertsil ODS-4
LB408 - Analysis of Fluconazole (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C18
LB407 - Analysis of Fluconazole (Under the Condition of the Japanese Pharmacopoeia, Fluconazole Capsules) -

LC InertSearch Inertsil WP300 C18
LB374 - Analysis of Ampiroxicam (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB373 - Analysis of Cyclophosphamide (Under the Condition of the Japanese Pharmacopoeia, Cyclophosphamide Tablets) -

LC InertSearch InertSustainSwift C18
LB372 - Analysis of Cyclophosphamide (Under the Condition of the Japanese Pharmacopoeia, Cyclophosphamide Tablets) -

LC InertSearch InertSustainSwift C18
LB371 - Analysis of Amlodipine besilate (Under the Condition of the Japanese Pharmacopoeia, Amlodipine Besilate Orally Disintegrating Tablets) -

LC InertSearch InertSustainSwift C18
LB369 - Analysis of Capsaicin (Under the Condition of the Japanese Pharmacopoeia, Capsicum Tincture) -

LC InertSearch InertSustain Phenyl
LB360 - Analysis of Roxithromycin (Under the Condition of the Japanese Pharmacopoeia, Roxithromycin Tablets) -

LC InertSearch InertSustain C18
LB339 - Analysis of Rebamipide (Under the Condition of the Japanese Pharmacopoeia, Rebamipide Tablets) -

LC InertSearch InertSustain C18
LB330 - Analysis of Roxithromycin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB329 - Analysis of Roxithromycin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C18
LB328 - Analysis of Roxithromycin (Under the Condition of the Japanese Pharmacopoeia 16th edition supplement II) -

LC InertSearch InertSustainSwift C18
LB327 - Analysis of Roxithromycin (Under the Condition of the Japanese Pharmacopoeia 16th edition) -

LC InertSearch InertSustainSwift C18
LB310 - Analysis of Voriconazole (Under the Condition of the Japanese Pharmacopoeia, Voriconazole Tablets) -

LC InertSearch Inertsil WP300 C18
LB309 - Analysis of Voriconazole (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB308 - Analysis of Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-4
LB307 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-4
LB306 - Analysis of Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-4
LB305 - Analysis of Candesartan cilexetil (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil WP300 C18
LB304 - Analysis of Candesartan cilexetil (Inertsil ODS-3) (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-3
LB303 - Analysis of Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-4
LB302 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-4
LB301 - Analysis of Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-4
LB300 - Analysis of Candesartan cilexetil (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil WP300 C18
LB299 - Analysis of Candesartan cilexetil (Inertsil ODS-3) (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil ODS-3
LB298 - Analysis of Candesartan cilexetil (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB295 - Analysis of Irbesartan (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB291 - Analysis of Ticlopidine hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Ticlopidine hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB290 - Analysis of Cefalexin (Under the Condition of the Japanese Pharmacopoeia, Cefalexin Combination Granules) -

LC InertSearch InertSustain C18
LB286 - Analysis of Ribavirin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4 HP
LB285 - Analysis of Ribavirin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4 HP
LB284 - Analysis of Silodosin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB283 - Analysis of Silodosin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB282 - Analysis of Povidone (Under the Condition of the Japanese Pharmacopoeia 16th edition, (4) 1-Vinyl-2-pyrrolidone) -

LC InertSearch InertSustain C8
LB281 - Analysis of Montelukast sodium (Inertsil Ph) (Under the Condition of the Japanese Pharmacopoeia, Montelukast sodium Tablets) -

LC InertSearch Inertsil Ph
LB265 - Analysis of Tacrolimus (Under the Condition of the Japanese Pharmacopoeia, Tacrolimus Capsules) -

LC InertSearch Inertsil ODS-2
LB264 - Analysis of Losartan Potassium and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Losartan Potassium and Hydrochlorothiazide Tablets) -

LC InertSearch Inertsil C8-3
LB262 - Analysis of Losartan Potassium and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Losartan Potassium and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustain C8
LB254 - Analysis of Brotizolam (Under the Condition of the Japanese Pharmacopoeia, Brotizolam Tablets) -

LC InertSearch Inertsil WP300 C18
LB253 - Analysis of Tranilast (Under the Condition of the Japanese Pharmacopoeia, Tranilast Capsules) -

LC InertSearch InertSustain C18
LB251 - Analysis of Quetiapine fumarate (Under the Condition of the Japanese Pharmacopoeia, Quetiapine fumarate Tablets) -

LC InertSearch Inertsil C8-4
LB250 - Analysis of Azelnidipine (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB247 - Analysis of Terbinafine hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Terbinafine hydrochloride Cream) -

LC InertSearch InertSustainSwift C18
LB246 - Analysis of L-Carbocisteine (Under the Condition of the Japanese Pharmacopoeia, L-Carbocisteine Tablets) -

LC InertSearch Inertsil ODS-4
LB245 - Analysis of L-Carbocisteine (Under the Condition of the Japanese Pharmacopoeia, L-Carbocisteine Tablets) -

LC InertSearch Inertsil ODS-4
LB243 - Analysis of Acarbose (Under the Condition of the Japanese Pharmacopoeia, Acarbose Tablets) -

LC InertSearch Inertsil WP300 C18
LB232 - Analysis of Leuprorelin acetate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C18 HP
LB231 - Analysis of Leuprorelin acetate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C18 HP
LB230 - Analysis of Leuprorelin acetate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustainSwift C18 HP
LB223 - Analysis of Cilnidipine (Under the Condition of the Japanese Pharmacopoeia, Cilnidipine Tablets) -

LC InertSearch Inertsil ODS-4
LB222 - Analysis of Butenafine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18 HP
LB210 - Analysis of Pioglitazone hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB209 - Analysis of Pioglitazone hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB205 - Analysis of Paroxetine hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Paroxetine hydrochloride Tablets) -

LC InertSearch Inertsil TMS
LB204 - Analysis of Metformin hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB203 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil Tablets) -

LC InertSearch Inertsil ODS-3
LB202 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil Tablets) -

LC InertSearch Inertsil ODS-3
LB201 - Analysis of Candesartan cilexetil (Inertsil ODS-3) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3
LB196 - Analysis of Ciprofloxacin hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Ciprofloxacin hydrochloride hydrate) -

LC InertSearch InertSustain C18
LB195 - Analysis of Metformin hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB194 - Analysis of Metformin hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB193 - Analysis of Pioglitazone hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB192 - Analysis of Pioglitazone hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB191 - Analysis of Metformin hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB190 - Analysis of Metformin hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB189 - Analysis of Pioglitazone hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB188 - Analysis of Pioglitazone hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB187 - Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) -

LC InertSearch InertSustain C18
LB186 - Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) -

LC InertSearch InertSustain C18
LB185 - Analysis of Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia,Chlorpheniramine maleate Tablets) -

LC InertSearch InertSustain C18
LB184 - Analysis of Phellodendron Bark (Inertsil ODS-3) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3
LB183 - Analysis of Phellodendron Bark (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB182 - Analysis of Glycyrrhiza (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB181 - Analysis of Glycyrrhiza (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB177 - Analysis of Povidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (8) 2-pyrrolidone) -

LC InertSearch InertSustain C18
LB176 - Analysis of Povidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (4) 1-Vinyl-2-pyrrolidone) -

LC InertSearch InertSustain C18
LB175 - Analysis of Loxoprofen (Under the Condition of the Japanese Pharmacopoeia, Loxoprofen sodium Tablets) -

LC InertSearch InertSustain C18
LB174 - Analysis of d-Chlorpheniramine maleate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3
LB173 - Analysis of Azelastine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB167 - Analysis of Crospovidone (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB166 - Analysis of Pravastatin Sodium (Under the Condition of the Japanese Pharmacopoeia,Pravastatin Sodium Tablets) -

LC InertSearch Inertsil WP300 C18
LB165 - Analysis of Pravastatin Sodium (Under the Condition of the Japanese Pharmacopoeia, Pravastatin Sodium Tablets) -

LC InertSearch Inertsil ODS-4
LB164 - Analysis of Telmisartan (Under the Condition of the Japanese Pharmacopoeia, Telmisartan Tablets) -

LC InertSearch Inertsil ODS-4
LB163 - Analysis of Telmisartan (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-SP
LB162 - Analysis of Clopidogrel sulfate (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia, Clopidogrel sulfate Tablets) -

LC InertSearch Inertsil WP300 C18
LB160 - Analysis of Clopidogrel sulfate (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB159 - Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB158 - Analysis of Clopidogrel sulfate (Inertsil WP300 C18) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB157 - Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB156 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) -

LC InertSearch Inertsil ODS-4
LB155 - Analysis of Amlodipine besylate (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) -

LC InertSearch Inertsil ODS-4
LB154 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) -

LC InertSearch Inertsil ODS-4
LB153 - Analysis of Candesartan cilexetil (Under the Condition of the Japanese Pharmacopoeia, Candesartan cilexetil and Amlodipine besylate Tablets) -

LC InertSearch Inertsil ODS-SP
LB152 - Analysis of Epinastine hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Epinastine Hydrochloride Tablets) -

LC InertSearch Inertsil C8-4
LB148 - Analysis of Cyanocobalamin (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB134 - Analysis of Fexofenadine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil Ph
LB133 - Analysis of Fexofenadine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil Ph
LB128 - Analysis of Teprenone (Under the Condition of the Japanese Pharmacopoeia, Teprenone Capsules) -

LC InertSearch Inertsil ODS-2
LB127 - Analysis of Etizolam (Under the Condition of the Japanese Pharmacopoeia, Etizolam Tablets) -

LC InertSearch Inertsil ODS-3
LB126 - Analysis of Risperidone (Under the Condition of the Japanese Pharmacopoeia, Risperidone Tablets) -

LC InertSearch Inertsil WP300 C18
LB125 - Analysis of Risperidone (Under the Condition of the Japanese Pharmacopoeia, Risperidone Tablets) -

LC InertSearch Inertsil WP300 C18
LB124 - Analysis of Ipriflavone (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB123 - Analysis of Ipriflavone (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB122 - Analysis of Simvastatin (Under the Condition of the Japanese Pharmacopoeia, Simvastatin Tablets) -

LC InertSearch Inertsil WP300 C18
LB121 - Analysis of Simvastatin (Under the Condition of the Japanese Pharmacopoeia, Simvastatin Tablets) -

LC InertSearch Inertsil WP300 C18
LB120 - Analysis of Simvastatin (Under the Condition of the Japanese Pharmacopoeia, Simvastatin Tablets) -

LC InertSearch Inertsil WP300 C18
LB119 - Analysis of Glimepiride (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3
LB118 - Analysis of Glimepiride (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3
LB117 - Analysis of Mecobalamin (Under the Condition of the Japanese Pharmacopoeia, Mecobalamin Tablets) -

LC InertSearch Inertsil ODS-4
LB116 - Analysis of Mecobalamin (Under the Condition of the Japanese Pharmacopoeia, Mecobalamin Tablets) -

LC InertSearch Inertsil ODS-4
LB115 - Analysis of Mecobalamin (Under the Condition of the Japanese Pharmacopoeia, Mecobalamin Tablets) -

LC InertSearch Inertsil ODS-4
LB114 - Analysis of Epalrestat (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB113 - Analysis of Epalrestat (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB112 - Analysis of Sivelestat sodium hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB111 - Analysis of Sivelestat sodium hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB106 - Analysis of Pitavastatin calcium tablets (Under the Condition of the draft for the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB104 - Analysis of Pitavastatin calcium (Under the Condition of the Japanese Pharmacopoeia, Pitavastatin calcium hydrate) -

LC InertSearch Inertsil ODS-4
LB103 - Analysis of Pilsicainide hydrochloride hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB102 - Analysis of Donepezil hydrochloride (Under the Condition of Japanese Pharmacopoeia, Donepezil hydrochloride tablets) -

LC InertSearch Inertsil ODS-2
LB101 - Analysis of Brotizolam (Under the Condition of the Japanese Pharmacopoeia, Brotizolam tablets) -

LC InertSearch Inertsil WP300 C18
LB100 - Analysis of p-Hydroxybenzoic acid n-butyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB098 - Analysis of p-Hydroxybenzoic acid n-propyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB097 - Analysis of p-Hydroxybenzoic acid ethyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB096 - Analysis of p-Hydroxybenzoic acid methyl ester (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB095 - Analysis of Edaravone Injection (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LB093 - Analysis of Pranlukast hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB092 - Analysis of Edaravone (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3
LB087 - Analysis of Naftopidil (Under the Condition of the Japanese Pharmacopoeia, Naftopidil Tablets) -

LC InertSearch InertSustain C18
LB086 - Analysis of Naftopidil (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB083 - Analysis of Ranitidine hydrochloride (Under the Condition of Japanese Pharmacopoeia 16) -

LC InertSearch ODS
LB066 - Analysis of Mosapride Citrate Tablets (Under the Condition of Japanese Pharmacopoeia 16) -

LC InertSearch InertSustain C18
LB065 - Analysis of Brotizolam(Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C8
LB064 - Analysis of Tranilast (Inertsil ODS-4)(Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB063 - Analysis of Tranilast (InertSustain C18)(Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB062 - Analysis of Cetiridine hydrochloride (Under the Condition of Japanese Pharmacopoeia, Cetiridine hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB061 - Analysis of Sarpogrelate Hydrochloride (Under the Condition of Japanese Pharmacopoeia 16) -

LC InertSearch Inertsil ODS-2
LB060 - Analysis of Quetiapine Fumarate (Under the Condition of the Japanese Pharmacopoeia, Quetiapine Fumarate Tablets) -

LC InertSearch Inertsil C8-4
LB059 - Analysis of Quetiapine Fumarate (Under the Condition of the Japanese Pharmacopoeia) -

LC InertSearch Inertsil C8-4
LB058 - Analysis of Amlodipine Besilate (Under the Condition of Japanese Pharmacopoeia, Amlodipine Besilate Tablets) -

LC InertSearch InertSustain C18
LB057 - Analysis of Acetylcysteine (Under the Condition of Japanese Pharmacopoeia 16) -

LC InertSearch Inertsil ODS-4
LB056 - Analysis of Olopatadine hydrochloride(Under the Condition of Japanese Pharmacopoeia, Olopatadine hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB055 - Analysis of Olopatadine hydrochloride (Under the Condition of Japanese Pharmacopoeia, Olopatadine hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB054 - Analysis of Olopatadine hydrochloride(Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch InertSustain C8
LB037 - Analysis of Terbinafine HCl (Inertsil ODS-4) (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-4
LB036 - Analysis of Terbinafine HCl (Inertsil ODS-3) (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3
LB035 - Analysis of Terbinafine HCl (InertSustain C18) (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LB025 - Analysis of Atorvastatin Calcium (Under the Condition of Japanese Pharmacopoeia, Atorvastatin Calcium Hydrate) -

LC InertSearch InertSustain C18
LB024 - Analysis of Atorvastatin Calcium (Under the Condition of Japanese Pharmacopoeia, Atorvastatin Calcium Tablets) -

LC InertSearch InertSustain C18
LB023 - Analysis of Atorvastatin Calcium (Under the Condition of Japanese Pharmacopoeia, Atorvastatin Calcium Tablets) -

LC InertSearch InertSustain C18
LB017 - Analysis of Furosemide(Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LA972 - Analysis of Loxoprofen- InertSustain C18(Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch InertSustain C18
LA971 - Analysis of Loxoprofen- Inertsil ODS-SP(Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-SP
LA970 - Analysis of Salicylic acid(Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-P
LA941 - Analysis of Terbinafine Chloride cream(Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LA940 - Analysis of Terbinafine Chloride(Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil WP300 C18
LA900 - Analysis of Lincomycin(Under the Condition of Japanese Pharmacopoeia 16) -

LC InertSearch Inertsil C8-4
LA899 - Analysis of Rifampicin(Under the Condition of Japanese Pharmacopoeia 16) -

LC InertSearch Inertsil C8-4
LA664 - Analysis of Clindamycin Phosphate (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil C8-4
LA663 - Analysis of Clindamycin Phosphate (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil C8-3
LA573 - Analysis of Scopolia Extract (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-SP
LA558 - Analysis of Scopolia Standard (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-SP
LA556 - Analysis of Toad Venom Extract (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-P
LA555 - Analysis of Toad Venom Extract (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-P
LA554 - Analysis of Voglibose by Post - Column HPLC (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch
LA553 - Analysis of Paeoniae radix extract(Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3
LA552 - Analysis of Paeoniae Standard (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-3
LA551 - Analysis of Glycyrrhiza Extract (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-SP
LA550 - Analysis of Glycyrrhiza Standard (Under the Condition of Japanese Pharmacopoeia) -

LC InertSearch Inertsil ODS-SP
GT093 - Quantitative Test for Hydroxypropylcellulose with Reference to the Japanese Pharmacopoeia, 17th Edition -

GC Technical Note InertCap 1 InertCap Series
GT087 - Purity Test of Olive Oil, with reference to the Japanese Pharmacopoeia, 16th Edition -Comparisons of Chromosorb Series and Uniport Series of Siliceous Soil Supports -

GC Technical Note
GT086 - Purity Test and Fatty Acid Content Ratio Test of Polysorbate 80 - Supplement II to the Japanese Pharmacopoeia, 16th Edition -

GC Technical Note InertCap Pure-WAX InertCap 5
GT085 - Water Testing of Panipenem - with Reference to the Japanese Pharmacopoeia 16th Edition -

GC Technical Note
GT083 - Purity Test of Calcium Polystyrene Sulfonate, with reference to the Japanese Pharmacopoeia, 16th Edition - Comparisons of Chromosorb Series and Uniport Series of Siliceous Soil Support -

GC Technical Note
GT056 - Purity Test of Colchicine with Reference to the Japanese Pharmacopoeia -

GC Technical Note InertCap Pure-WAX
GT054 - Purity Test of Epirubicin Hydrochloride with Reference to the Japanese Pharmacopoeia -

GC Technical Note InertCap WAX
GT034 - Purity Test of Benzyl Alcohol with Reference to the Japanese Pharmacopoeia -

GC Technical Note InertCap Pure-WAX
GA281 - Residual solvents in pharmaceuticals -

GC InertSearch InertCap WAX
GA275 - Analysis of Hydroxypropyl Cellulose(Under the Condition of the draft for the Japanese Pharmacopoeia) -

GC InertSearch InertCap 1
GA274 - Analysis of Tulobuterol Transdermal Tapes(Under the Condition of the draft for the Japanese Pharmacopoeia) -

GC InertSearch InertCap 1
GA269 - 2-Pyrrolidone -

GC InertSearch InertCap Pure-WAX
GA268 - Analysis of Sevoflurane(Under the Condition of Japanese Pharmacopoeia 16) -

GC InertSearch InertCap 624
GA267 - Analysis of Sevoflurane(Under the Condition of Japanese Pharmacopoeia 16) -

GC InertSearch InertCap 624
GA266 - Analysis of Sevoflurane(Under the Condition of Japanese Pharmacopoeia 16) -

GC InertSearch InertCap 624
GA265 - Propylene glycol(Under the Condition of Japanese Pharmacopoeia 16) -

GC InertSearch InertCap 1701
GA264 - Propylene glycol(Under the Condition of Japanese Pharmacopoeia 16) -

GC InertSearch InertCap 1701
GA263 - Glycerin, Concentrated glycerin(Under the Condition of Japanese Pharmacopoeia 16) -

GC InertSearch InertCap 1701
GA262 - Glycerin, Concentrated glycerin(Under the Condition of Japanese Pharmacopoeia 16) -

GC InertSearch InertCap 1701
GA251 - Analysis of Stearic Acid(Under the Condition of Japanese Pharmacopoeia 16) -

GC InertSearch InertCap Pure-WAX
GA248 - Analysis of Iohexol(Under the Condition of the Japanese Pharmacopoeia 16) -

GC InertSearch InertCap 5
GA247 - Analysis of Iohexol(Under the Condition of the Japanese Pharmacopoeia 16) -

GC InertSearch InertCap 5
GA246 - Analysis of Bupivacaine hydrochloride hydrate(Under the Condition of Japanese Pharmacopoeia 16) -

GC InertSearch InertCap 5
GA244 - Analysis of Clomifene Citrate(Under the Condition of Japanese Pharmacopoeia 16) -

GC InertSearch InertCap 1 Custom-made
GA210 - Propylene glycol,Diethylene glycol,Ethylene glycol -

GC InertSearch InertCap 1701
GA209 - Glycerin,Diethylene glycol,Ethylene glycol -

GC InertSearch InertCap 1701
GA203 - Organic solvents -

GC InertSearch TC-BOND U
GA202 - Organic solvents -

GC InertSearch TC-BOND Q
GA167 - Purity test of Benzyl alcohol by Japanese pharmacopoeia -

GC InertSearch InertCap WAX
GA166 - Purity test of Epirubicin Hydrochloride by Japanese pharmacopoeia -

GC InertSearch InertCap Pure-WAX
GA165 - Purity test of Magnesium stearate by Japanese pharmacopoeia -

GC InertSearch InertCap WAX
GA164 - Purity test of Magnesium stearate by Japanese pharmacopoeia -

GC InertSearch InertCap Pure-WAX
GA155 - Purity test of Colchicine by Japanese pharmacopoeia -

GC InertSearch InertCap Pure-WAX
GA154 - Purity test of Wood Creosote by Japanese pharmacopoeia -

GC InertSearch InertCap 1
GA151 - Purity test of Acethexamide -

GC InertSearch InertCap 1
GA145 - Purity test of Colchicine -

GC InertSearch InertCap WAX
GA144 - Purity test of Epirubicin Hydrochloride -

GC InertSearch InertCap WAX
GA134 - Higher Alcohols -

GC InertSearch InertCap 5
GA128 - Residual solvents in pharmaceuticals -

GC InertSearch InertCap 5
GA127 - Residual solvents in pharmaceuticals Class3 -

GC InertSearch InertCap 5
GA126 - Residual solvents in pharmaceuticals Class2 -

GC InertSearch InertCap 5
GA125 - Residual solvents in pharmaceuticals Class1 -

GC InertSearch InertCap 5
GA124 - Residual solvents in pharmaceuticals -

GC InertSearch InertCap 5
GA123 - Residual solvents in pharmaceuticals -

GC InertSearch InertCap 624
GA100 - Glycol ＆ Glycerine -

GC InertSearch InertCap 1701
GA099 - Glycol ＆ Glycerine -

GC InertSearch InertCap 1
GA097 - Organic solvents -

GC InertSearch InertCap Pure-WAX
GA096 - Organic solvents -

GC InertSearch InertCap 624
GA094 - Residual solvents in pharmaceuticals Class3 -

GC InertSearch InertCap Pure-WAX
GA093 - Residual solvents in pharmaceuticals Class3 -

GC InertSearch InertCap 624
GA092 - Residual solvents in pharmaceuticals Class2 -

GC InertSearch InertCap Pure-WAX
GA091 - Residual solvents in pharmaceuticals Class2 -

GC InertSearch InertCap 624
GA090 - Residual solvents in pharmaceuticals Class1 -

GC InertSearch InertCap Pure-WAX
GA089 - Residual solvents in pharmaceuticals Class1 -

GC InertSearch InertCap 624
GA087 - Organic solvents -

GC InertSearch InertCap Pure-WAX
GA086 - Organic solvents -

GC InertSearch InertCap Pure-WAX
GA084 - Organic solvents -

GC InertSearch InertCap Pure-WAX
GA079 - Organic solvents -

GC InertSearch InertCap Pure-WAX
GA078 - Organic solvents -

GC InertSearch InertCap Pure-WAX
GA071 - Glycerin, Diethylene glycol -

GC InertSearch InertCap 1701
GA037 - Organic solvents -

GC InertSearch InertCap WAX
GA036 - Organic solvents -

GC InertSearch InertCap 5
GA035 - Organic solvents -

GC InertSearch InertCap 1701
GA034 - Organic solvents -

GC InertSearch InertCap 17
GA033 - Organic solvents -

GC InertSearch InertCap 1
GA028 - Organic solvents -

GC InertSearch InertCap 25
GA027 - Organic solvents -

GC InertSearch InertCap 5MS/Sil
GA026 - Organic solvents -

GC InertSearch InertCap AQUATIC-2
GA023 - Organic solvents -

GC InertSearch InertCap WAX
GA012 - Organic solvents -

GC InertSearch InertCap 1

Applications including "Japanese pharmacopoeia"

LT199 - Analysis of voglibose tablets in accordance with the 18th revised Japanese Pharmacopoeia -

LT195 - Eighteenth revision Japanese Pharmacopoeia analysis of tranexamic acid -2.00 Condition change within the range specified in the general chromatography- -

GT146 - Japanese Pharmacopoeia, 18th Edition Analysis of Saccharin Sodium Hydrate - 2.00 Change of Conditions Specified within General Theory of Chromatography -

GT145 - Japanese Pharmacopoeia, 18th Edition Analysis of Macrogol 400 - 2.00 Change of Conditions Specified within General Theory of Chromatography -

LB263 - Analysis of Losartan Potassium and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia, Losartan Potassium and Hydrochlorothiazide Tablets) -

LB206 - Analysis of Paroxetine hydrochloride (Under the Condition of the Japanese Pharmacopoeia) -

LB161 - Analysis of Clopidogrel sulfate (InertSustain C18) (Under the Condition of the Japanese Pharmacopoeia, Clopidogrel sulfate Tablets) -

LB099 - Analysis of p-Hydroxybenzoic acid n-butyl ester (Under the Condition of Japanese Pharmacopoeia) -

LB094 - Analysis of Pranlukast hydrate (Under the Condition of the Japanese Pharmacopoeia) -

LB085 - Analysis of Olmesartan medoxomil (Under the Condition of the Japanese Pharmacopoeia) -

GA271 - Analysis of Polysorbate80(Under the Condition of Japanese Pharmacopoeia 16) -

GA270 - Analysis of Polysorbate80(Under the Condition of Japanese Pharmacopoeia 16) -

GA113 - Residual solvents in pharmaceuticals -

GA029 - Organic solvents -

LB849 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -

LB848 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -

LB806 - Analysis of Ampicillin and Sulbactam (Under the Condition of the Japanese Pharmacopoeia 18th , Ampicillin Sodium and Sulbactam Sodium for Injection) -

LB761 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LB760 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LB759 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LB758 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LB757 - Analysis of Fenofibrate (Under the Condition of the Japanese Pharmacopoeia 18th) -

LB756 - Analysis of Fenofibrate (Under the Condition of the Japanese Pharmacopoeia 18th) -

LB755 - Analysis of Oxaliplatin (Under the Condition of the draft for the Japanese Pharmacopoeia18th supplement II) -

LB754 - Analysis of Saccharin (Under the Condition of the Japanese Pharmacopoeia 18th, Saccharin Sodium Hydrate) -

GA342 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GA341 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GA340 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GA339 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GA338 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GA337 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

LB699 - Analysis of Refined Glucose (Japanese Pharmacopoeia 18th Edition, Glucose, Assay) -

GA335 - Analysis of Benzyl Alcohol (Under the condition of the Japanese Pharmacopoeia 18) -

GA333 - Residual solvents in pharmaceuticals (JP 18 Standard stock solution Class 2 C) -

GA332 - Residual solvents in pharmaceuticals (JP 18 Standard stock solution Class 2 C) -

GA331 - Residual solvents in pharmaceuticals (JP 18 Standard stock solution Class 2 C) -

GA330 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GA329 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GA328 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GA327 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GA326 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GA325 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GA324 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GA323 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GA322 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

LB669 - Analysis of Rosuvastatin calcium (Under the condition of the Japanese Pharmacopoeia (JP) ) -

LB641 - Analysis of Rosuvastatin Calcium (Under the Condition of draft for Japanese Pharmacopoeia, Rosuvastatin Calcium) -

LB640 - Analysis of Rosuvastatin Calcium (Under the Condition of draft for Japanese Pharmacopoeia, Rosuvastatin Calcium) -

LB632 - Analysis of Telmisartan and Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LB631 - Analysis of Telmisartan and Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LB630 - Analysis of Amlodipine besilate (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LB629 - Analysis of Telmisartan (Under the Condition of Japanese Pharmacopoeia, Telmisartan and Amlodipine Besilate Tablets) -

LB628 - Analysis of Copovidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (7) 2-Pyrrolidone) -

LB627 - Analysis of Copovidone (Under the Condition of the draft for the Japanese Pharmacopoeia, (4) 1-Vinyl-2-pyrrolidone and vinyl acetate) -

LT147 - D-Mannitol Analysis Under USP Method -

LT131 - HPLC Columns Compliant with Pharmacopoeia (USP, EP and JP） -

LT092 - Analysis of Tranexamic Acid According to the Japanese Pharmacopoeia -

LT080 - Analysis of Sennosides in Senna in Accordance with the Japanese Pharmacopoeia -

LT052 - Analysis of Geniposide with a Photodiode Array Detection -

LT044 - Analysis of Bufosteroids in Senso In Accordance with the Japanese Pharmacopoeia -

LT040 - Analysis of peony (Chinese paeoniflorin) in accordance with the 15th edition of the Japanese Pharmacopoeia -

LT039 - Analysis of Glycyrrhizic Acid in Licorice According to the Japanese Pharmacopoeia -

LT038 - Analysis of Scopolamine and Hyoscyamine in Scopolia Extract in Accordance with the Japanese Pharmacopoeia -

LB532 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets B) -

LB531 - Analysis of Sodium Valproate (Under the Condition of the draft for the Japanese Pharmacopoeia, Sodium Valproate Extended-release Tablets A) -

LB529 - Analysis of Carnosine (Under the Condition of the draft for the Japanese Pharmacopoeia, Poraprezinc Granules) -

LB528 - Analysis of Carnosine (Under the Condition of the draft for the Japanese Pharmacopoeia, Poraprezinc) -

LB527 - Analysis of Dexamathasone Sodium Phosphate (Under the Condition of the draft for the Japanese Pharmacopoeia, Dexamathasone Sodium Phosphate) -

LB526 - Analysis of Dexamathasone Sodium Phosphate (Under the Condition of the draft for the Japanese Pharmacopoeia, Dexamathasone Sodium Phosphate) -

LB525 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of the draft for the Japanese Pharmacopoeia, Telmisartan and Hydrochlorothiazide Tablets) -

LB524 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of the Japanese Pharmacopoeia supplement II, Telmisartan and Hydrochlorothiazide Tablets) -

LB523 - Analysis of Telmisartan and Hydrochlorothiazide (Under the Condition of the draft for the Japanese Pharmacopoeia, Telmisartan and Hydrochlorothiazide Tablets) -

LB520 - Analysis of Valsartan and Hydrochlorothiazide(Under the Condition of the draft for the Japanese Pharmacopoeia, Valsartan and Hydrochlorothiazide Tablets) -

LB519 - Analysis of Valsartan and Hydrochlorothiazide(Under the Condition of the draft for the Japanese Pharmacopoeia, Valsartan and Hydrochlorothiazide Tablets) -

LB508 - Analysis of Sitagliptin (Under the Condition of the draft for the Japanese Pharmacopoeia, Sitagliptin Phosphate Hydrate) -

LB503 - Analysis of Warfarin Potassium (Under the Condition of the Japanese Pharmacopoeia 17th edition, (3) Related subatances) -

LB502 - Analysis of Warfarin Potassium (Under the Condition of the Japanese Pharmacopoeia 17th edition) -

LB489 - Analysis of Azosemide (Under the Condition of the draft for the Japanese Pharmacopoeia, Azosemide Tablets) -

LB487 - Analysis of Verapamil Hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Verapamil Hydrochloride Tablets) -